Twenty-four-month alpha-galactosidase A replacement therapy in Fabry disease has only minimal effects on symptoms and cardiovascular parameters (Q42657184)
Jump to navigation
Jump to search
scientific article published on 23 May 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Twenty-four-month alpha-galactosidase A replacement therapy in Fabry disease has only minimal effects on symptoms and cardiovascular parameters |
scientific article published on 23 May 2008 |
Statements
1 reference
Twenty-four-month alpha-galactosidase A replacement therapy in Fabry disease has only minimal effects on symptoms and cardiovascular parameters (English)
1 reference
1 reference
J W Koskenvuo
1 reference
J J Hartiala
1 reference
P Nuutila
1 reference
R Kalliokoski
1 reference
J S Viikari
1 reference
E Engblom
1 reference
M Penttinen
1 reference
I Mononen
1 reference
I M Kantola
1 reference
23 May 2008
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference